FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2811194320> ?p ?o ?g. }

• W2811194320 endingPage "240" @default.
• W2811194320 startingPage "233" @default.
• W2811194320 abstract "Introduction: Isoniazid prevention therapy alone can reduce the risk of tuberculosis in people with HIV regardless of CD4 count or antiretroviral treatment. In Ethiopia, there is scarcity of evidence on implementation of isoniazid prevention therapy and factors associated with its uptake. Objective: The study aimed to assess isoniazid preventive therapy implementation and factors associated with isoniazid completion among human immunodeficiency virus infected children in Felege-Hiwot and Gondar University Referral Hospitals in Northwest Ethiopia. Methods: A facility-based cross-sectional study using a combination of face-to-face interviews of caregivers/parents and retrieval of client records was conducted in May 2014. Trained nurses with experience in human immunodeficiency virus infection and tuberculosis care conducted the document review and interviews. Data were entered onto Epi Info version 3.5.4 for windows, cleaned and exported to Statistical Package for Social Sciences version 20.0 for windows for analysis. Results: A total of 454 HIV infected children (51.8% females and 48.2% males) were studied. Nearly a third, 168 (37%),of children were provided isoniazid prevention therapy and 67.9% completed the full course. Isoniazid completion was associated with distance from hospital (p<0.005), explanation of the reasons to take isoniazid pills (p<0.001), thinking isoniazid may be dangerous to child’s health (p<0.001), believing that the chance of getting sick from tuberculosis is high for the child (p<0.001), disclosure of human immunodeficiency virus infection status (p<0.04) and isoniazid preventive therapy disclosure status (p<0.001). Conclusions: Uptake of isoniazid preventive therapy was low among human immunodeficiency virus infected children. In addition, isoniazid therapy completion was very low. The hospitals and Regional Health Bureau should avail isoniazid preventive therapy in the nearby health facilities and strengthen adequate counseling on the role of isoniazid preventive therapy for tuberculosis. Key words: Tuberculosis; isoniazid preventive therapy; completion; children; Ethiopia." @default.
• W2811194320 created "2018-07-10" @default.
• W2811194320 creator A5050371838 @default.
• W2811194320 creator A5085734072 @default.
• W2811194320 date "2018-06-29" @default.
• W2811194320 modified "2023-09-27" @default.
• W2811194320 title "ISONIAZID PREVENTIVE THERAPY UPTAKE AND COMPLETION AMONG HIV INFECTED CHILDREN IN TWO REFERRAL HOSPITALS, NORTHWEST ETHIOPIA" @default.
• W2811194320 cites W1986207517 @default.
• W2811194320 cites W2002935662 @default.
• W2811194320 cites W2020867877 @default.
• W2811194320 cites W2037304683 @default.
• W2811194320 cites W2037640424 @default.
• W2811194320 cites W2066527389 @default.
• W2811194320 cites W2076315508 @default.
• W2811194320 cites W2104567479 @default.
• W2811194320 cites W2105395527 @default.
• W2811194320 cites W2168090599 @default.
• W2811194320 cites W2187272624 @default.
• W2811194320 hasPublicationYear "2018" @default.
• W2811194320 type Work @default.
• W2811194320 sameAs 2811194320 @default.
• W2811194320 citedByCount "0" @default.
• W2811194320 crossrefType "journal-article" @default.
• W2811194320 hasAuthorship W2811194320A5050371838 @default.
• W2811194320 hasAuthorship W2811194320A5085734072 @default.
• W2811194320 hasConcept C142724271 @default.
• W2811194320 hasConcept C159110408 @default.
• W2811194320 hasConcept C187212893 @default.
• W2811194320 hasConcept C2776135927 @default.
• W2811194320 hasConcept C2776967927 @default.
• W2811194320 hasConcept C2781069245 @default.
• W2811194320 hasConcept C512399662 @default.
• W2811194320 hasConcept C71924100 @default.
• W2811194320 hasConcept C81603835 @default.
• W2811194320 hasConceptScore W2811194320C142724271 @default.
• W2811194320 hasConceptScore W2811194320C159110408 @default.
• W2811194320 hasConceptScore W2811194320C187212893 @default.
• W2811194320 hasConceptScore W2811194320C2776135927 @default.
• W2811194320 hasConceptScore W2811194320C2776967927 @default.
• W2811194320 hasConceptScore W2811194320C2781069245 @default.
• W2811194320 hasConceptScore W2811194320C512399662 @default.
• W2811194320 hasConceptScore W2811194320C71924100 @default.
• W2811194320 hasConceptScore W2811194320C81603835 @default.
• W2811194320 hasIssue "3" @default.
• W2811194320 hasLocation W28111943201 @default.
• W2811194320 hasOpenAccess W2811194320 @default.
• W2811194320 hasPrimaryLocation W28111943201 @default.
• W2811194320 hasVolume "56" @default.
• W2811194320 isParatext "false" @default.
• W2811194320 isRetracted "false" @default.
• W2811194320 magId "2811194320" @default.
• W2811194320 workType "article" @default.